Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular Domains

Epidermal growth factor (EGF) regulates cell proliferation and differentiation by binding to the EGF receptor (EGFR) extracellular region, comprising domains I-IV, with the resultant dimerization of the receptor tyrosine kinase. In this study, the crystal structure of a 2:2 complex of human EGF and the EGFR extracellular region has been determined at 3.3 A resolution. EGFR domains I-III are arranged in a C shape, and EGF is docked between domains I and III. The 1:1 EGF*EGFR complex dimerizes through a direct receptor*receptor interaction, in which a protruding beta-hairpin arm of each domain II holds the body of the other. The unique "receptor-mediated dimerization" was verified by EGFR mutagenesis.

[1]  A. Burgess,et al.  Structure-Function relationships for the EGF/TGF-α family of mitogens , 1994 .

[2]  S. Takahashi,et al.  A site-directed mutagenesis study on the role of isoleucine-23 of human epidermal growth factor in the receptor binding. , 1992, Biochimica et Biophysica Acta.

[3]  A. Ullrich,et al.  Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences , 1984, Nature.

[4]  M. O’Connor-McCourt,et al.  The extracellular domain of the epidermal growth factor receptor. Studies on the affinity and stoichiometry of binding, receptor dimerization and a binding-domain mutant. , 1994, European journal of biochemistry.

[5]  龍喜 荒尾,et al.  メラノサイト系腫瘍におけるGrowth factor receptorの局在 , 1990 .

[6]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[7]  Waterfield,et al.  Analysis of mammalian fibroblast transformation by normal and mutated human EGF receptors. , 1989, Oncogene.

[8]  J. Navaza,et al.  AMoRe: an automated package for molecular replacement , 1994 .

[9]  S. Yokoyama,et al.  Recognition of an antiparallel β‐sheet structure of human epidermal growth factor by its receptor Site‐directed mutagenesis studies of Ala‐30 and Asn‐32 , 1992, FEBS letters.

[10]  Crystallization and preliminary X-ray crystallographic analysis of the EGF receptor ectodomain. , 1998, Acta crystallographica. Section D, Biological crystallography.

[11]  S. Cohen,et al.  Epidermal growth factor , 1972, The Journal of investigative dermatology.

[12]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[13]  Y. Yarden,et al.  A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor , 1996, Molecular and cellular biology.

[14]  Toshio Yanagida,et al.  Single-molecule imaging of EGFR signalling on the surface of living cells , 2000, Nature Cell Biology.

[15]  B. Sykes,et al.  NMR study of the differential contributions of residues of transforming growth factor alpha to association with its receptor. , 2000, Protein engineering.

[16]  T. Ooi,et al.  The erbB gene of avian erythroblastosis virus is a member of the src gene family , 1983, Cell.

[17]  L. Hood,et al.  Rat transforming growth factor type 1: structure and relation to epidermal growth factor. , 1984, Science.

[18]  J. Chai,et al.  Crystal Structure of Human Epidermal Growth Factor and Its Dimerization* , 2001, The Journal of Biological Chemistry.

[19]  D. Engler,et al.  Biochemical properties of site-directed mutants of human epidermal growth factor: importance of solvent-exposed hydrophobic residues of the amino-terminal domain in receptor binding. , 1990, Biochemistry.

[20]  Monilola A. Olayioye,et al.  The ErbB signaling network: receptor heterodimerization in development and cancer , 2000, The EMBO journal.

[21]  Thomas C. Terwilliger,et al.  Electronic Reprint Biological Crystallography Maximum-likelihood Density Modification , 2022 .

[22]  C. Betzel,et al.  The secreted form of the epidermal growth factor receptor. Characterization and crystallization of the receptor-ligand complex. , 1990, The Journal of biological chemistry.

[23]  Kazuki Saito,et al.  Chimeric receptor analyses of the interactions of the ectodomains of ErbB-1 with epidermal growth factor and of those of ErbB-4 with neuregulin. , 2002, European journal of biochemistry.

[24]  C. A. Guyer,et al.  Identification of Residues of the Epidermal Growth Factor Receptor Proximal to Residue 45 of Bound Epidermal Growth Factor* , 1996, The Journal of Biological Chemistry.

[25]  J. Brugge,et al.  Controlled Dimerization of ErbB Receptors Provides Evidence for Differential Signaling by Homo- and Heterodimers , 1999, Molecular and Cellular Biology.

[26]  Christian Wiesmann,et al.  Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor , 1999, Nature.

[27]  J. Stroh,et al.  The Structural Basis for the Specificity of Epidermal Growth Factor and Heregulin Binding (*) , 1995, The Journal of Biological Chemistry.

[28]  H. Kawasaki,et al.  A 40-kDa epidermal growth factor/transforming growth factor alpha-binding domain produced by limited proteolysis of the extracellular domain of the epidermal growth factor receptor. , 1993, The Journal of biological chemistry.

[29]  W R Taylor,et al.  On the tertiary structure of the extracellular domains of the epidermal growth factor and insulin receptors. , 1987, Biochimica et biophysica acta.

[30]  S. Yokoyama,et al.  Characterization of the N-oligosaccharides attached to the atypical Asn-X-Cys sequence of recombinant human epidermal growth factor receptor. , 2000, Journal of biochemistry.

[31]  R. Jorissen,et al.  Identification of a determinant of epidermal growth factor receptor ligand-binding specificity using a truncated, high-affinity form of the ectodomain. , 2001, Biochemistry.

[32]  S. Hubbard,et al.  Structural Basis for FGF Receptor Dimerization and Activation , 1999, Cell.

[33]  C. Ward,et al.  Insulin and epidermal growth factor receptors contain the cysteine repeat motif found in the tumor necrosis factor receptor , 1995, Proteins.

[34]  D. Kohda,et al.  Three-dimensional nuclear magnetic resonance structures of mouse epidermal growth factor in acidic and physiological pH solutions. , 1994, Biochemistry.

[35]  I. Lax,et al.  Disulfide Bond Structure of Human Epidermal Growth Factor Receptor* , 1998, The Journal of Biological Chemistry.

[36]  E. Chen,et al.  Human transforming growth factor-α: Precursor structure and expression in E. coli , 1984, Cell.

[37]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[38]  Joseph Schlessinger,et al.  Crystal Structures of Two FGF-FGFR Complexes Reveal the Determinants of Ligand-Receptor Specificity , 2000, Cell.

[39]  W. Hendrickson,et al.  Structural interactions of fibroblast growth factor receptor with its ligands. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[40]  D. Engelman,et al.  Two EGF molecules contribute additively to stabilization of the EGFR dimer , 1997, The EMBO journal.

[41]  L. Wang,et al.  Human epidermal growth factor (EGF) receptor sequence recognized by EGF competitive monoclonal antibodies. Evidence for the localization of the EGF-binding site. , 1989, The Journal of biological chemistry.

[42]  Robert M. Stroud,et al.  Efficiency of signalling through cytokine receptors depends critically on receptor orientation , 1998, Nature.

[43]  E C Nice,et al.  Stoichiometry, Kinetic and Binding Analysis of the Interaction between Epidermal Growth Factor (EGF) and the Extracellular Domain of the EGF Receptor , 2000, Growth factors.

[44]  I. Lax,et al.  Ligand-binding enhances the affinity of dimerization of the extracellular domain of the epidermal growth factor receptor. , 1997, Journal of biochemistry.

[45]  N. Hynes,et al.  ErbB‐2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling , 1997, The EMBO journal.

[46]  David F. Burke,et al.  Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin , 2000, Nature.

[47]  L. Wang,et al.  Human epidermal growth factor receptor residue covalently cross-linked to epidermal growth factor. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[48]  P. Seeburg,et al.  Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells , 1984, Nature.

[49]  M. Ultsch,et al.  Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. , 1992, Science.

[50]  Russ Miller,et al.  The design and implementation of SnB version 2.0 , 1999 .

[51]  A. Ullrich,et al.  Functional analysis of the ligand binding site of EGF‐receptor utilizing chimeric chicken/human receptor molecules. , 1989, The EMBO journal.

[52]  J. Schlessinger,et al.  Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. , 2000, Molecular cell.

[53]  I. Campbell,et al.  The solution structure of human transforming growth factor alpha. , 1993, European journal of biochemistry.

[54]  R. Woltjer,et al.  Direct identification of residues of the epidermal growth factor receptor in close proximity to the amino terminus of bound epidermal growth factor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[55]  N. Kunishima,et al.  Atomic structure of the GCSF–receptor complex showing a new cytokine–receptor recognition scheme , 1999, Nature.

[56]  Edouard C. Nice,et al.  Crystal Structure of a Truncated Epidermal Growth Factor Receptor Extracellular Domain Bound to Transforming Growth Factor α , 2002, Cell.

[57]  H. Wiley,et al.  The Enhanced Tumorigenic Activity of a Mutant Epidermal Growth Factor Receptor Common in Human Cancers Is Mediated by Threshold Levels of Constitutive Tyrosine Phosphorylation and Unattenuated Signaling* , 1997, The Journal of Biological Chemistry.

[58]  Joseph Schlessinger,et al.  Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.

[59]  N. Mckern,et al.  Crystal structure of the first three domains of the type-1 insulin-like growth factor receptor , 1998, Nature.